We describe here an optimized protocol of fluorescent Electrophoretic Mobility Shift Assays (fEMSA) using purified SOX-2 proteins together with infrared fluorescent dye-labeled DNA probes as a case study to tackle an important biological question.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
We describe here an optimized protocol of fluorescent Electrophoretic Mobility Shift Assays (fEMSA) using purified SOX-2 proteins together with infrared fluorescent dye-labeled DNA probes as a case study to tackle an important biological question.
Electrophoretic Mobility Shift Assays (EMSA) are an instrumental tool to characterize the interactions between proteins and their target DNA sequences. Radioactivity has been the predominant method of DNA labeling in EMSAs. However, recent advances in fluorescent dyes and scanning methods have prompted the use of fluorescent tagging of DNA as an alternative to radioactivity for the advantages of easy handling, saving time, reducing cost, and improving safety. We have recently used fluorescent EMSA (fEMSA) to successfully address an important biological question. Our fEMSA analysis provides mechanistic insight into the effect of a missense mutation, G73E, in the highly conserved HMG transcription factor SOX-2 on olfactory neuron type diversification. We found that mutant SOX-2G73E protein alters specific DNA binding activity, thereby causing olfactory neuron identity transformation. Here, we present an optimized and cost-effective step-by-step protocol for fEMSA using infrared fluorescent dye-labeled oligonucleotides containing the LIM-4/SOX-2 adjacent target sites and purified SOX-2 proteins (WT and mutant SOX-2G73E proteins) as a biological example.
EMSAs are used to analyze interactions between DNA and proteins by using native PolyAcrylamide Gel Electrophoresis (PAGE) to resolve a mixture of a protein of interest and a labeled DNA probe containing potential target sites of the protein1. A DNA probe bound with protein will migrate slower compared with a free DNA probe, and is therefore retarded in its migration through a polyacrylamide matrix. Radiolabeling of DNA by 32P has been the predominant method for detection in EMSAs. Although the application of radiolabeling in biochemical research has been beneficial, methods of alternative DNA labeling with comparable sensitivity are being employe....
Access restricted. Please log in or start a trial to view this content.
NOTE: EMSAs using fluorescently labeled DNA probes or other forms of labeled DNA share the same protocols for protein or cell extract preparation, protein-DNA binding reaction, and PAGE gel preparation and running (Figure 1A). The key differences are DNA labeling procedures, post-run gel processing steps, and detection methods.
1. Gel Preparation
Access restricted. Please log in or start a trial to view this content.
Orange G loading dye (6x: 0.12 g Orange G in 100 mL 30% Glycerol) can be added to the binding reaction prior to loading to visualize the progress of the electrophoresis. Other loading dyes including bromophenol blue will be detected during scanning and therefore interfere with image analysis (Figure 1B).
In some instances of EMSAs, especially if nuclear extract preparation is used, poly deoxyinosinic-deoxycytidy.......
Access restricted. Please log in or start a trial to view this content.
fEMSAs are an efficient tool to investigate protein-DNA interactions, and are an alternative to radioactive labeling of DNA. Fluorescent dyes such as infrared dyes are commercially available, and provide a safer and more environmentally friendly method compared to radioactive DNA labeling. EMSAs using infrared fluorescent dye-labeled oligonucleotides do not require postrun gel processing steps, and therefore save time and cost compared to other DNA labeling techniques. The time to detect bands using radioactive EMSAs can.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
This work was supported by an Alfred P. Sloan Research Fellowship (to C.-F.C.) and an NIH R01 grant (5R01GM098026-05 to C.-F.C.). We thank David Crowe for access to the advanced infrared imaging system.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 30% Acrylamide/Bis Solution, 37.5:1 | Bio-Rad | 1610158 | Acrylamide is harmful and toxic. |
| 6x-His Epitope Tag Antibody (HIS.H8) | ThermoFisher | MA1-21315 | |
| Anti-Flag M2 antibody | Sigma-Aldrich | F3165-.2MG | |
| Bovine Serum Albumin (BSA) molecular biology grade | New England Biolabs | B9000S | |
| 5'IRDye700-labeled DNA Oligos | Integrated DNA Technologies | Custom DNA oligo | These are referred to as "5'Dye-labeled or infrared fluorescent dye-labeled DNA oligos" in the manuscript. The company will custom synthesize 5' IRDye labeled-DNA oligonucleotides. Requires minimum 100 μM scale synthesis and HPLC purification. |
| Klenow Fragment (3'-->5' exo-) | New England Biolabs | M0212S | |
| LightShif Poly (dI-dC) | ThermoFisher | 20148E | |
| Mini-PROTEAN Vertical Electrophoresis Cell | Bio-Rad | 1658000FC | This is referred to as a 'mini protein gel system' in the manuscript. Any electrophoretic system can be used as long as they are clear glass plates of less than 25 cm x 25 cm in size. |
| Odyssey CLx Infrared Imaging System | LI-COR Biotechnology | Odyssey CLx Infrared Imagng System | This is referred to as an 'advanced infrared imaging system' in the manuscript. |
| Odyssey Fc Imaging System | LI-COR Biotechnology | Odyssey Fc Dual-Mode Imaging System | This is referred as a 'near-infrared fluorescent imaging system primarily for Western blots' in the manuscript. |
| Image Studio software (version 4.0) | LI-COR Biotechnology | Image Studio software | This is referred to as a 'particular imaging software' in the manuscript. |
| Orange G | Sigma-Aldrich | O3756-25G | |
| 6x Orange loading dye | 0.25% Orange G; 30% Glycerol | ||
| 0.5x TBE | 45 mM Tris-Borate; 1 mM EDTA | ||
| 1x TE | 10 mM Tris-HCl, pH 8.0; 1 mM EDTA | ||
| 1x STE | 100 mM NaCl; 10 mM Tris-HCl, pH 8.0; 1 mM EDTA | ||
| 5x Binding Buffer | 50 mM Tris-HCl, pH 7.5; 50 mM NaCl; 200 mM KCl; 5 mM MgCl2; 5 mM EDTA, pH 8.0; 5 mM DTT; 250 μg/mL BSA |
Access restricted. Please log in or start a trial to view this content.